# Blood Formation, Coagulation, and Thrombosis Agents: HeparinRelated Preparations

## LENGTH OF AUTHORIZATIONS

Varies based upon criteria below

## PRIOR AUTHORIZATION CRITERIA

1. Is there any reason the patient cannot be changed to a medication not requiring prior approval?

    Acceptable reasons include:

    - Allergy to medications not requiring prior approval

    - Contraindication to all medications not requiring prior approval

    - History of unacceptable/toxic side effects to medications not requiring prior approval

2. Has the patient failed a therapeutic trial of 14 days with a medication not requiring prior approval?

## DURATION OF THERAPY LIMIT

35 days

Guidelines from the American College of Chest Physicians limit duration of therapy in the outpatient setting for most indications to less than 35 days. Patients should be transitioned to oral warfarin as soon as possible.

Is there any reason the patient cannot be changed to oral warfarin? Acceptable reasons include:

- Patients with cancer (approved up to 180 days),

- Pregnant women (approved up to 280 days), or

- Patients unable to take warfarin (approved up to 180 days).

## Heparin-Related Preparations

| Blood Formation, Coagulation, and Thrombosis Agents: Heparin-Related Preparations |              |
|-----------------------------------------------------------------------------------|--------------|
| PREFERRED                                                                         | NONPREFERRED |
| Enoxaparin                                                                        | Fondaparinux |
|                                                                                   | Fragmin      |

### Link to Criteria

[Blood Formation, Coagulation, and Thrombosis Agents: Heparin-Related Preparations](https://pharmacy.medicaid.ohio.gov/sites/default/files/20220415_UPDL_Criteria_FINAL_.pdf#page=12)
